The effect of remote ischemic conditioning (RIC) on functional outcomes in patients with acute stroke.
Revolution Medicines breaks ground in challenging pancreatic cancer with two RAS drugs
In an interview Friday, Revolution Medicines CEO Mark Goldsmith, who says he prefers to understate rather than exaggerate, floated a lofty goal: cure pancreatic cancer